TNF and soft tissue sarcoma: Recombinant tumor necrosis factor (TNF) in combination with melphalan has gained marketing authorization in Europe for the treatment of unresectable soft tissue sarcoma, in which TNF is administered through isolated limb perfusion procedure [7].